Army scientists working as part of an international consortium have developed and tested an antibody-based therapy to treat Crimean-Congo hemorrhagic fever virus (CCHFV), which is carried by ticks and kills up to 60 percent of those infected. Their results are published online today in the journal Cell.
- Read more about New therapy for crimean congo hemorrhagic fever developed by researchers
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/new-therapy-for-crimean-congo-hemorrhagic-fever-developed-by-researchers
No comments:
Post a Comment